18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
Status:
Recruiting
Trial end date:
2027-05-01
Target enrollment:
Participant gender:
Summary
This is a pilot imaging study in participants treated with stereotactic radiosurgery (SRS) to
treat brain metastasis. The purpose of this study is to see whether 18F-Fluciclovine positron
emission tomography (PET) can be used as a biomarker to measure response or progression of
brain metastasis after SRS.